Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 26, 2021; 9(21): 5769-5781
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5769
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5769
Figure 1 Proposed algorithm for the screening and prevention of hepatitis B virus reactivation.
anti-HBc: Hepatitis B core antibodies; ALT: Alanine aminotransferase; ETV: Entecavir; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus; LAM: Lamivudine; TAF: Tenofovir alafenamide; TDF: Tenofovir disoproxil fumarate.
- Citation: Shih CA, Chen WC. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. World J Clin Cases 2021; 9(21): 5769-5781
- URL: https://www.wjgnet.com/2307-8960/full/v9/i21/5769.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i21.5769